Crohn's & Colitis Foundation Executive and Leadership Team

Michael Osso, the President & Chief Executive Officer at Crohn's & Colitis Foundation, directs the overarching strategic vision for this non-profit organization. By aligning research initiatives with patient advocacy goals, the President & Chief Executive Officer ensures that resources effectively target the discovery of cures for Crohn's disease and ulcerative colitis. This leadership role involves managing high-level partnerships with medical institutions and donor networks to sustain long-term organizational growth. Michael Osso oversees the integration of volunteer-fueled programs across North American markets, ensuring that every initiative directly improves the quality of life for children and adults. Through rigorous oversight of fiscal health and mission-driven programming, the President & Chief Executive Officer maintains the foundation's status as a leader in digestive health advocacy. By fostering collaboration among internal departments, Osso secures the necessary momentum to achieve transformative medical breakthroughs.

Sharon Lungrin, the Chief Operating Officer at Crohn's & Colitis Foundation, manages the daily execution of organizational programs and internal infrastructure. By streamlining administrative workflows, the Chief Operating Officer ensures that volunteer-driven efforts remain efficient and scalable across diverse regional chapters. This role requires constant coordination with department heads to optimize resource allocation for patient support services and research funding. Sharon Lungrin monitors operational performance metrics to guarantee that the foundation meets its ambitious goals for disease awareness and community engagement. Through the implementation of robust management systems, the Chief Operating Officer supports the broader mission of improving life quality for patients nationwide. Lungrin drives operational excellence by refining internal processes, which allows the organization to maximize the impact of every dollar raised. Ultimately, the Chief Operating Officer provides the structural foundation necessary for the successful delivery of critical health resources to the patient community.

Stephanie Brock, the President of the Board of Directors at Crohn's & Colitis Foundation, leads the governing body responsible for setting the long-term strategic direction of the organization. By facilitating board meetings and committee oversight, the President of the Board of Directors ensures that the foundation remains dedicated to its mission of finding cures for Crohn's disease and ulcerative colitis. This role involves recruiting and engaging diverse leadership talent to support the foundation's growth and sustainability. Stephanie Brock monitors the performance of executive leadership to ensure alignment with the organization's core values and financial objectives. Through the promotion of strong governance practices, the President of the Board of Directors maintains the trust of donors and the patient community. Brock drives the strategic vision by fostering consensus among board members on critical research and advocacy priorities. By providing high-level guidance, the President of the Board of Directors secures the foundation's future impact on global digestive health.

Mark Bovenizer, the President of the Board of Trustees - Jersey Chapter at Crohn's & Colitis Foundation, directs regional efforts to increase awareness and support for patients within the local community. By mobilizing volunteers and organizing fundraising events, the President of the Board of Trustees - Jersey Chapter ensures that the foundation's national mission translates into tangible local impact. This role involves building relationships with regional medical providers and patient advocacy groups to expand the reach of support services. Mark Bovenizer oversees the allocation of chapter resources to maximize the effectiveness of local educational programs and patient outreach. Through the coordination of regional initiatives, the President of the Board of Trustees - Jersey Chapter strengthens the foundation's presence and influence. Bovenizer drives community engagement by fostering a collaborative environment for volunteers and donors. By leading the Jersey Chapter, the President of the Board of Trustees - Jersey Chapter contributes significantly to the overall success of the foundation's national goals.

Jeffrey Mittleman, the President of the Board of Trustees at Crohn's & Colitis Foundation, oversees the fiduciary responsibilities and strategic oversight of the foundation's assets. By ensuring that financial resources are directed toward high-impact research and patient support, the President of the Board of Trustees maintains the integrity of the organization's mission. This role involves working closely with the executive team to evaluate the success of ongoing programs and to identify new opportunities for growth. Jeffrey Mittleman leads the board in establishing policies that promote transparency and accountability across all levels of the foundation. Through the careful management of institutional priorities, the President of the Board of Trustees ensures that the organization remains a leader in the fight against Crohn's disease and ulcerative colitis. Mittleman drives the board's commitment to excellence by fostering a culture of strategic inquiry and collaboration. By providing steady leadership, the President of the Board of Trustees supports the foundation's long-term sustainability.

Jeffrey Ward, the Board Member and Board President (Volunteer Position) at Crohn's & Colitis Foundation, provides essential leadership and strategic guidance on a volunteer basis. By leveraging professional expertise to advise on organizational development, the Board Member and Board President (Volunteer Position) helps shape the foundation's approach to research funding and patient advocacy. This role involves participating in key decision-making processes that influence the direction of the foundation's medical and community programs. Jeffrey Ward supports the executive team by offering insights that enhance the effectiveness of fundraising and awareness campaigns. Through the dedication of time and specialized knowledge, the Board Member and Board President (Volunteer Position) strengthens the foundation's ability to serve those affected by inflammatory bowel diseases. Ward drives the board's mission-focused agenda by championing initiatives that prioritize patient needs. By serving in this capacity, the Board Member and Board President (Volunteer Position) exemplifies the volunteer-fueled spirit that defines the foundation's success.

Nikki Pavone-Liberto, the President at Crohn's & Colitis Foundation, leads specific organizational divisions focused on expanding the foundation's reach and influence. By directing the implementation of strategic initiatives, the President ensures that the foundation effectively addresses the needs of patients and their families. This role involves managing key relationships with stakeholders to secure the resources necessary for advancing research and improving quality of life. Nikki Pavone-Liberto oversees the execution of programs that promote awareness and provide critical support to those living with Crohn's disease and ulcerative colitis. Through the coordination of departmental efforts, the President maintains a focus on achieving measurable outcomes that align with the foundation's mission. Pavone-Liberto drives operational success by fostering innovation in patient services and community engagement. By providing leadership across these vital areas, the President ensures that the foundation continues to make significant progress toward its ultimate goal of discovering cures for these chronic conditions.

Rohit Suri, the Chief Technology Officer at Crohn's & Colitis Foundation, architects the digital infrastructure required to support large-scale research data and patient outreach platforms. By deploying advanced software solutions, the Chief Technology Officer enables seamless communication between medical researchers and the patient population. This role involves securing sensitive data while enhancing the accessibility of educational resources through digital channels. Rohit Suri oversees the integration of modern technology stacks to improve the efficiency of fundraising campaigns and volunteer management systems. Through the strategic application of data analytics, the Chief Technology Officer identifies trends that inform future research priorities and patient support initiatives. Suri drives digital transformation across the organization, ensuring that technological capabilities remain aligned with the evolving needs of the medical community. By maintaining a secure and innovative technical environment, the Chief Technology Officer empowers the foundation to reach more individuals affected by inflammatory bowel diseases.

Orna Ehrlich, the Chief of Staff and Impact at Crohn's & Colitis Foundation, coordinates cross-functional initiatives to ensure that organizational activities generate measurable improvements in patient outcomes. By evaluating the efficacy of various programs, the Chief of Staff and Impact aligns internal efforts with the core mission of finding cures for Crohn's disease and ulcerative colitis. This role involves facilitating communication between executive leadership and the board to maintain focus on high-priority impact goals. Orna Ehrlich monitors the progress of research grants and community support services to verify that these investments yield significant benefits for the patient population. Through the synthesis of performance data, the Chief of Staff and Impact provides actionable insights that guide future strategic planning. Ehrlich drives the assessment of organizational success, ensuring that every project contributes to the long-term vision of the foundation. By fostering a culture of accountability, the Chief of Staff and Impact maximizes the value delivered to those affected by these chronic conditions.

Marisa Mayer, the Chief Legal Officer at Crohn's & Colitis Foundation, manages all regulatory compliance and legal risk mitigation for the organization. By overseeing intellectual property matters related to medical research and clinical trials, the Chief Legal Officer protects the foundation's interests while fostering innovation. This role involves drafting and negotiating complex agreements with research partners and corporate sponsors to ensure ethical and legal alignment. Marisa Mayer provides guidance on governance policies, ensuring that all volunteer-fueled activities adhere to non-profit regulations and standards. Through the proactive management of legal affairs, the Chief Legal Officer safeguards the reputation and assets of the foundation. Mayer drives the development of internal policies that support transparent operations and effective collaboration across all departments. By navigating the intricate legal landscape of medical research, the Chief Legal Officer enables the organization to focus on its primary objective of discovering cures for inflammatory bowel diseases.